Recent News

Share
and/or

Connect with us

16 News Items found
In the Clinic
New Trial Advances Cell-Based Immune Therapy for Certain Leukemias

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.
In the Lab
Pictured: Stem cell-derived nerve cells exposed to progerin
Researchers Fast-Forward Stem Cell Aging to Study Degenerative Diseases

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.
In the Clinic
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
In the Lab
Pictured: Michel Sadelain
New Technique Could Make Cell-Based Immune Therapies for Cancer Safer and More Effective

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.
Announcement
Pictured: Michel Sadelain & Jedd Wolchok
Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Immunology “Dream Team”

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.
Q&A
Pictured: Lorenz Studer
Developmental Biologist Lorenz Studer Comments on the 2012 Nobel Prize in Physiology or Medicine

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.